$OPAD
Offerpad Solutions Inc Stock $opad

$opad Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000095017022002999 Filed on March 07, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$867.5M	$540.3M	$2.070B
YoY Change	288.63%	189.91%	94.54%
Cost Of Revenue	$797.2M	$487.2M	$1.863B
YoY Change		192.42%	90.75%
Gross Profit	$70.29M	$53.12M	$207.8M
YoY Change	178.33%	168.77%	136.75%
Gross Profit Margin	8.1%	9.83%	10.04%
Selling, General & Admin	$63.76M	$46.89M	$177.2M
YoY Change	23925.02%	133.82%	87.97%
% of Gross Profit	90.71%	88.26%	85.26%
Research & Development	$3.197M	$2.777M	$10.86M
YoY Change		70.06%	49.38%
% of Gross Profit	4.55%	5.23%	5.23%
Depreciation & Amortization	$90.00K	$100.0K	$500.0K
YoY Change		0.0%	25.0%
% of Gross Profit	0.13%	0.19%	0.24%
Operating Expenses	$66.96M	$49.66M	$188.0M
YoY Change	25129.66%	129.01%	85.2%
Operating Profit	$3.335M	$3.458M	$19.77M
YoY Change	686.56%	-280.01%	-243.67%
Interest Expense	-$6.178M	$5.495M	$15.85M
YoY Change	-75.37%	318.83%	57.99%
% of Operating Profit	-185.25%	158.91%	80.18%
Other Income/Expense, Net	$15.65M	-$18.68M	-$13.14M
YoY Change		1726.0%	42.83%
Pretax Income	$12.81M	-$15.22M	$6.600M
YoY Change	-150.52%	417.05%	-128.7%
Income Tax	$0.00	-$81.00K	$170.0K
% Of Pretax Income	0.0%		2.58%
Net Earnings	$12.81M	-$15.30M	$6.460M
YoY Change	-1070.89%	419.8%	-127.94%
Net Earnings / Revenue	1.48%	-2.83%	0.31%
Basic Earnings Per Share	$0.05	-$0.13	$0.05
Diluted Earnings Per Share	$0.05	-$0.13	$0.05
COMMON SHARES
Basic Shares Outstanding		116.0M	118.6M
Diluted Shares Outstanding		116.0M	143.2M

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$169.8M	$116.6M	$169.8M
YoY Change	15629.18%		15629.18%
Cash & Equivalents	$169.8M	$116.6M
Short-Term Investments
Other Short-Term Assets	$34.42M	$30.48M	$34.42M
YoY Change	8388.85%	5995.4%	8388.85%
Inventory	$1.133B	$902.1M	$1.133B
Prepaid Expenses
Receivables	$6.165M	$10.04M	$6.165M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.343B	$1.059B	$1.343B
YoY Change	490.86%	211742.2%	90326.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.146M	$9.556M	$9.930M
YoY Change	-37.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.959M	$193.0K	$175.0K
YoY Change	1308.81%
Total Long-Term Assets	$10.11M	$9.749M	$10.11M
YoY Change	17.73%	-30241.6%	-97.49%
TOTAL ASSETS
Total Short-Term Assets	$1.343B	$1.059B	$1.343B
Total Long-Term Assets	$10.11M	$9.749M	$10.11M
Total Assets	$1.353B	$1.069B	$1.353B
YoY Change	473.65%	228478.27%	234.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.399M	$6.126M	$6.399M
YoY Change	197.77%	24955.21%	16341.42%
Accrued Expenses	$35.03M	$28.35M	$35.03M
YoY Change	213.27%	9564.76%	12574.41%
Deferred Revenue
YoY Change
Short-Term Debt	$1.026B	$751.0M	$1.026B
YoY Change		750941.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.068B	$785.5M	$1.068B
YoY Change	461.03%	181350.5%	333500.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.830M	$39.71M	$27.89M
YoY Change	-94.0%		-56.33%
Total Long-Term Liabilities	$3.830M	$39.71M	$27.89M
YoY Change	-94.0%		-56.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.068B	$785.5M	$1.068B
Total Long-Term Liabilities	$3.830M	$39.71M	$27.89M
Total Liabilities	$1.096B	$825.2M	$1.096B
YoY Change	461.78%	176264.79%	1606.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$132.1M	-$144.9M
YoY Change	-4.66%	573474.6%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change	-100.0%
Treasury Stock Shares
Shareholders Equity	$257.6M	$243.7M	$257.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.353B	$1.069B	$1.353B
YoY Change	473.65%	228478.27%	234.87%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	$12.81M	-$15.30M	$6.460M
YoY Change	-1070.89%	419.8%	-127.94%
Depreciation, Depletion And Amortization	$90.00K	$100.0K	$500.0K
YoY Change		0.0%	25.0%
Cash From Operating Activities	-$217.1M	-$704.0M	-$921.9M
YoY Change	44057.26%		-695.31%
INVESTING ACTIVITIES
Capital Expenditures	-$78.00K	-$13.61M	$13.69M
YoY Change			378.9%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.032M	$2.032M
YoY Change	-100.0%		-100.5%
Cash From Investing Activities	-$78.00K	-$11.58M	-$11.66M
YoY Change	-99.98%		307.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$51.25M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	275.0M	802.3M	1.077B
YoY Change	-31.95%		-921.42%
NET CHANGE
Cash From Operating Activities	-217.1M	-704.0M	-921.9M
Cash From Investing Activities	-78.00K	-11.58M	-11.66M
Cash From Financing Activities	275.0M	802.3M	1.077B
Net Change In Cash	57.78M	86.71M	143.7M
YoY Change	5251.37%		588.87%
FREE CASH FLOW
Cash From Operating Activities	-$217.1M	-$704.0M	-$921.9M
Capital Expenditures	-$78.00K	-$13.61M	$13.69M
Free Cash Flow	-$217.0M	-$690.4M	-$935.6M
YoY Change			-715.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2020Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2020	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities
CY2020	opad	Proceeds From Business Combination ProceedsFromBusinessCombination
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019	opad	Transaction Costs TransactionCosts
CY2020Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.offerpad.com/20211231#AccruedAndOtherCurrentLiabilities
CY2020	opad	Transaction Costs TransactionCosts
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2019	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2020Q4	opad	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	0
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2021Q4	us-gaap	Other Notes Payable OtherNotesPayable	0
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2021Q4	opad	Secured Credit Facilities And Notes Payable Net Of Current Portion SecuredCreditFacilitiesAndNotesPayableNetOfCurrentPortion
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	0
CY2020Q4	opad	Warrant Liabilities WarrantLiabilities
CY2020Q4	us-gaap	Secured Debt Other SecuredDebtOther	0
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019	opad	Proceeds From Business Combination ProceedsFromBusinessCombination
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001825024
CY2020Q4	opad	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	0
CY2021Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.offerpad.com/20211231#AccruedAndOtherCurrentLiabilities
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLongTermDebtNoncurrent
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39641
CY2021	dei	Entity Registrant Name EntityRegistrantName	Offerpad Solutions Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2800538
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 E. Germann Road
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Chandler
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85286
CY2021	dei	City Area Code CityAreaCode	844
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Local Phone Number LocalPhoneNumber	388-4539
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	399700
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Auditor Location AuditorLocation	Phoenix, Arizona
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169817000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43938000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	24616000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	6804000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6165000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2309000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1132571000
CY2020Q4	us-gaap	Inventory Net InventoryNet	171359000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9808000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2880000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1342977000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	227290000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5146000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8231000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4959000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	352000
CY2021Q4	us-gaap	Assets Assets	1353082000
CY2020Q4	us-gaap	Assets Assets	235873000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6399000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2149000
CY2021Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	35027000
CY2020Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	11181000
CY2021Q4	opad	Secured Credit Facilities And Notes Payable SecuredCreditFacilitiesAndNotesPayable	861762000
CY2020Q4	opad	Secured Credit Facilities And Notes Payable SecuredCreditFacilitiesAndNotesPayable	50143000
CY2021Q4	opad	Secured Credit Facilities And Notes Payable Net Related Party SecuredCreditFacilitiesAndNotesPayableNetRelatedParty	164434000
CY2020Q4	opad	Secured Credit Facilities And Notes Payable Net Related Party SecuredCreditFacilitiesAndNotesPayableNetRelatedParty	126825000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1067622000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	190298000
CY2020Q4	opad	Secured Credit Facilities And Notes Payable Net Of Current Portion SecuredCreditFacilitiesAndNotesPayableNetOfCurrentPortion	4710000
CY2021Q4	opad	Warrant Liabilities WarrantLiabilities	24061000
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10650000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	257569000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-143258000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1353082000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	235873000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2070446000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1064257000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1075882000
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3830000
CY2021Q4	us-gaap	Liabilities Liabilities	1095513000
CY2020Q4	us-gaap	Liabilities Liabilities	195008000
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	184123000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	389601000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5908000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132056000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138516000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1862631000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	976478000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	1001495000
CY2021	us-gaap	Gross Profit GrossProfit	207815000
CY2020	us-gaap	Gross Profit GrossProfit	87779000
CY2019	us-gaap	Gross Profit GrossProfit	74387000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	146872000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76786000
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	85226000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30317000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17481000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15111000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10860000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7270000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7450000
CY2021	us-gaap	Operating Expenses OperatingExpenses	188049000
CY2020	us-gaap	Operating Expenses OperatingExpenses	101537000
CY2019	us-gaap	Operating Expenses OperatingExpenses	107787000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	19766000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13758000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-33400000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2464000
CY2021	us-gaap	Interest Expense InterestExpense	15848000
CY2020	us-gaap	Interest Expense InterestExpense	10031000
CY2019	us-gaap	Interest Expense InterestExpense	18298000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	248000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	834000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13136000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9197000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18298000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6630000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22955000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51698000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	254000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-51952000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118571000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57865000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57848000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143220000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57865000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57848000
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	79699000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-60339000
CY2019	opad	Issuance Of Series C Stock Net Of Offering Costs IssuanceOfSeriesCStockNetOfOfferingCosts	74601000
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10650000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1268000
CY2019	opad	Stock Issued During Period Shares Early Exercise Of Stock Options StockIssuedDuringPeriodSharesEarlyExerciseOfStockOptions	170000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-51952000
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	154300000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-121503000
CY2020	opad	Issuance Of Series C Stock Net Of Offering Costs IssuanceOfSeriesCStockNetOfOfferingCosts	29823000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1363000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	184123000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-143258000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	647000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0
CY2021	opad	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	171000
CY2021	opad	Temporary Conversion Of Preferred Stock To Common Stock Amount TemporaryConversionOfPreferredStockToCommonStockAmount	-184123000
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	184123000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	206347000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3079000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	257569000
CY2021	us-gaap	Profit Loss ProfitLoss	6460000
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	40000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2843000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	3170000
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	3002000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3079000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1363000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1268000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2464000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3845000
CY2020	us-gaap	Profit Loss ProfitLoss	-23118000
CY2019	us-gaap	Profit Loss ProfitLoss	-51952000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	523000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	434000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	377000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	246000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	916000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	262000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-937000
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1075000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	949591000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-169079000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60731000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5288000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-115000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	937000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4130000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	841000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2421000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	21563000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1781000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3455000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-921920000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	154864000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-108974000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13687000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2858000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1039000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2032000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	60000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11655000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2858000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-979000
CY2021	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	284011000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-51249000
CY2021	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	2764071000
CY2020	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	799997000
CY2021	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	1912837000
CY2020	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	960510000
CY2019	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	1019347000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7632000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	457000
CY2019	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	1077781000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10650000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1077266000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-131147000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	122503000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	143691000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20859000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12550000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29883000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17333000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194433000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29883000
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	52000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	902000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	170000
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	29823000
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	74601000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169817000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43938000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22856000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	24616000
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	6804000
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	7027000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194433000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29883000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	21875000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	14048000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	20008000
CY2021	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	14464000
CY2020	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	0
CY2019	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	0
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	26525000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	184123000
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant estimates include those related to the net realizable value of inventory and warrant liabilities, among others. Actual results could differ from those estimates.</span></p>
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q4	opad	Accrued Home Renovation Payable Current AccruedHomeRenovationPayableCurrent	8540000
CY2020Q4	opad	Accrued Home Renovation Payable Current AccruedHomeRenovationPayableCurrent	1057000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5795000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentrations of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents. Cash and cash equivalents are placed with major financial institutions deemed to be of high-credit-quality in order to limit credit exposure. Cash is regularly maintained in excess of federally insured limits at the financial institutions. Management believes that the Company is not exposed to any significant credit risk related to cash deposits.</span></p>
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2800000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	3200000
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	3000000.0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Warrant Liabilities</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company evaluates its financial instruments, including its outstanding warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company has outstanding public and private warrants, both of which do not meet the criteria for equity classification and are accounted for as liabilities. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, the Company recognizes the warrants as liabilities at fair value and adjusts the warrants to fair value at each reporting period. The warrant liabilities are subject to re-measurement at each balance sheet date until exercised or expired, and any change in fair value is recognized in the Company’s consolidated statements of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the public warrants is estimated based on the quoted market price of such warrants. The fair value of the private warrants is estimated using the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Black-Scholes-Merton option-pricing model.</span></p>
CY2021	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Revenue Recognition</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is recognized when (or as) performance obligations are satisfied by transferring control of the promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services. The Company applies the following steps in determining the timing and amount of revenue to recognize: (1) identify the contract with our customer; (2) identify the performance obligation(s) in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract, if applicable; and (5) recognize revenue when (or as) the performance obligation is satisfied.</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue from the sale of homes is derived from the resale of homes on the open market. Home sales revenue is recognized at the time of the closing when title to and possession of the property are transferred to the buyer. The amount of revenue recognized for each home sale is equal to the sale price of the home net of resale concessions and credits to the buyer.</span></p>
CY2021	us-gaap	Advertising Expense AdvertisingExpense	45300000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	11500000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	17300000
CY2021Q3	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	284000000.0
CY2021Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	51200000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	63400
CY2021Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	327455000
CY2020Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	47978000
CY2021Q4	us-gaap	Inventory Finished Homes InventoryFinishedHomes	400308000
CY2020Q4	us-gaap	Inventory Finished Homes InventoryFinishedHomes	30826000
CY2021Q4	opad	Inventory Homes Under Contract To Sell InventoryHomesUnderContractToSell	404808000
CY2020Q4	opad	Inventory Homes Under Contract To Sell InventoryHomesUnderContractToSell	92555000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1132571000
CY2020Q4	us-gaap	Inventory Net InventoryNet	171359000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6615000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9286000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1469000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1055000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5146000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8231000
CY2021	us-gaap	Depreciation Depreciation	500000
CY2020	us-gaap	Depreciation Depreciation	400000
CY2019	us-gaap	Depreciation Depreciation	400000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1400000
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1525000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1637000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1585000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	640000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	122000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	42000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5551000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	376000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5175000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4784000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1345000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3830000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5175000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12836000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7430000
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1035000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3537000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	699000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1743000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	314000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1345000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1231000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	646000
CY2021Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	35027000
CY2020Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	11181000
CY2021Q4	us-gaap	Secured Debt Other SecuredDebtOther	33320000
CY2020Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	2385000
CY2020Q4	us-gaap	Other Notes Payable OtherNotesPayable	5309000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6923000
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	208000
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1026196000
CY2020Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	181678000
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	861762000
CY2020Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	50143000
CY2021Q4	opad	Notes And Loans Payable Related Parties Current NotesAndLoansPayableRelatedPartiesCurrent	164434000
CY2020Q4	opad	Notes And Loans Payable Related Parties Current NotesAndLoansPayableRelatedPartiesCurrent	126825000
CY2020Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	4710000
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1026196000
CY2020Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	181678000
CY2021Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1385000000
CY2021	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	829440000
CY2020Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	425000000
CY2020	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	154941000
CY2021	opad	Number Of Facilities NumberOfFacilities	4
CY2021	opad	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0
CY2021	opad	Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate	2026-09-01
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2370000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4015000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.81
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M2D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22106000
CY2019	opad	Share Based Compensation Arrangement By Share Based Payment Award Options Retroactive Conversion Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRetroactiveConversionOfShares	26232000
CY2019	opad	Share Based Compensation Arrangement By Share Based Payment Award Options Retroactive Conversion Of Shares Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRetroactiveConversionOfSharesWeightedAverageExercisePrice	-2.44
CY2018Q4	opad	Share Based Compensation Arrangement By Share Based Payment Award Shares Converted Due To Business Combination ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesConvertedDueToBusinessCombination	30247000
CY2018Q4	opad	Share Based Compensation Arrangement By Share Based Payment Award Shares Converted Due To Business Combination Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesConvertedDueToBusinessCombinationWeightedAverageExercisePrice	0.37
CY2018	opad	Share Based Compensation Arrangement By Share Based Payment Award Shares Converted Due To Business Combination Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesConvertedDueToBusinessCombinationWeightedAverageRemainingContractualTerm	P8Y10M2D
CY2018Q4	opad	Share Based Compensation Arrangement By Share Based Payment Award Shares Converted Due To Business Combination Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesConvertedDueToBusinessCombinationAggregateIntrinsicValue	22106000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3375000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.24
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	576000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.29
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9377000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.25
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23669000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.55
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M15D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16275000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5258000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1336000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.54
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27591000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.68
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14619000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1559000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2490000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.36
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1084000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.85
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25576000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.73
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	137170000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	19065000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.62
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M21D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	86526000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	25576000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.73
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	137170000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3100000
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1400000
CY2019	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1300000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4900000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-51952000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118571000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57865000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57848000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24644000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	5000
CY2020	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	0
CY2019	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	0
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2019	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143220000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57865000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57848000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6600000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23000000.0
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51700000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	170000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	163000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	254000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	163000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	254000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	254000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1392000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4821000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10857000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	647000
CY2021	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	0.098
CY2020	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	286000
CY2020	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	-0.012
CY2019	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	266000
CY2019	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	-0.005
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	360000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.054
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-446000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.019
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2003000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039
CY2021	opad	Transaction Costs TransactionCosts	-1226000
CY2021	opad	Transaction Costs Percentage TransactionCostsPercentage	-0.185
CY2020	opad	Transaction Costs Percentage TransactionCostsPercentage	0.000
CY2019	opad	Transaction Costs Percentage TransactionCostsPercentage	0.000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-675000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.102
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4999000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.218
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12363000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.239
CY2021	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities	-517000
CY2021	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	-0.078
CY2020	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	0.000
CY2019	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	0.000
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	189000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.029
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	145000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.006
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	485000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.010
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.026
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	254000
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	26721000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	27847000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4703000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5133000
CY2021Q4	opad	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	1284000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2762000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1892000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35470000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	34872000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33336000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34011000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2134000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	871000
CY2021Q4	opad	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	-1187000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	874000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	865000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	73000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2134000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	871000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-700000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5000000.0
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12400000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	1182000
CY2020	us-gaap	Related Party Costs RelatedPartyCosts	693000
CY2019	us-gaap	Related Party Costs RelatedPartyCosts	601000
CY2021Q4	opad	Contractual Obligation To Purchase Home ContractualObligationToPurchaseHome	2182
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	658800000
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	1600000
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1200000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	867540000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	540287000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378647000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	283972000
CY2021Q4	us-gaap	Gross Profit GrossProfit	70292000
CY2021Q3	us-gaap	Gross Profit GrossProfit	53122000
CY2021Q2	us-gaap	Gross Profit GrossProfit	50864000
CY2021Q1	us-gaap	Gross Profit GrossProfit	33537000
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3335000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3458000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	11529000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1444000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	12806000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-15303000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	9190000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-233000
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	223230000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186365000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	287007000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	367655000
CY2020Q4	us-gaap	Gross Profit GrossProfit	25255000
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2020Q3	us-gaap	Gross Profit GrossProfit	19765000
CY2020Q2	us-gaap	Gross Profit GrossProfit	17861000
CY2020Q1	us-gaap	Gross Profit GrossProfit	24898000
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	424000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1921000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5240000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7021000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-1319000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-2944000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7390000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-11465000
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20

Files In Submission

Name	View Source	Status
0000950170-22-002999-index-headers.html	Edgar Link	pending
0000950170-22-002999-index.html	Edgar Link	pending
0000950170-22-002999.txt	Edgar Link	pending
0000950170-22-002999-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img220811429_0.jpg	Edgar Link	pending
img220811429_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opad-20211231.htm	Edgar Link	pending
opad-20211231.xsd	Edgar Link	pending
opad-20211231_cal.xml	Edgar Link	unprocessable
opad-20211231_def.xml	Edgar Link	unprocessable
opad-20211231_htm.xml	Edgar Link	completed
opad-20211231_lab.xml	Edgar Link	unprocessable
opad-20211231_pre.xml	Edgar Link	unprocessable
opad-ex10_12.htm	Edgar Link	pending
opad-ex10_5.htm	Edgar Link	pending
opad-ex10_8.htm	Edgar Link	pending
opad-ex21_1.htm	Edgar Link	pending
opad-ex23_1.htm	Edgar Link	pending
opad-ex31_1.htm	Edgar Link	pending
opad-ex31_2.htm	Edgar Link	pending
opad-ex32_1.htm	Edgar Link	pending
opad-ex32_2.htm	Edgar Link	pending
opad-ex4_4.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPAD
Offerpad Solutions Inc Stock $opad

2021 Q4 Form 10-K Financial Statement

#000095017022002999 Filed on March 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPAD Offerpad Solutions Inc Stock $opad

2021 Q4 Form 10-K Financial Statement

#000095017022002999 Filed on March 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPAD
Offerpad Solutions Inc Stock $opad